Watson Biotech: Announcement on relinquishing priority purchase rights of Shanghai Zerun Biotechnology Co., Ltd. to be transferred by Huisheng (China) Investment Co., Ltd.

SZSI · Nov 4, 2020 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.